Dec 12 (Reuters) - CARL ZEISS MEDITEC AG AFXG.DE :
* INCREASED REVENUE IN FISCAL YEAR 2022/23 BY AROUND 10
PERCENT
* COMPANY CONSIDERS OUTLOOK FOR FISCAL YEAR 2023/24 TO BE
LARGELY
POSITIVE, AS UNDERLYING LONG-TERM DEVELOPMENT TRENDS CONTINUE TO
PERSIST
* EBIT IS EXPECTED BE AT ROUGHLY SAME LEVEL AS IN PRIOR YEAR
IN
FISCAL YEAR 2023/24
* REVENUE GROWTH FOR FISCAL YEAR 2023/24 AS A WHOLE IS
EXPECTED TO
BE AT LEAST AS HIGH AS MARKET GROWTH
* EBIT AND EBIT MARGIN SHOULD BE HIGHER AGAIN IN SECOND HALF
OF
2023/24 THAN IN SECOND HALF OF 2022/23
* IN MEDIUM TERM, COMPANY EXPECTS TO BE ABLE TO STABILIZE
ITS EBIT
MARGIN SUSTAINABLY ABOVE 20%
* MANAGEMENT BOARD AND SUPERVISORY BOARD PLAN TO PROPOSE A
DIVIDEND OF EUR 1.10 TO ANNUAL GENERAL MEETING, UNCHANGED FROM
PRIOR YEAR
Source text for Eikon: ID:nEQ9bxH9Pa
Further company coverage: AFXG.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))